AMRZ
Amrize LtdNYSEBASIC MATERIALSBUILDING MATERIALS
Key Statistics
Market Cap
$30.27B
P/E Ratio
25.51
EPS
$2.14
Beta
—
52W High
$65.94
52W Low
$44.12
50-Day MA
$57.76
200-Day MA
$53.00
Dividend Yield
—
Profit Margin
10.00%
Forward P/E
18.66
PEG Ratio
1.44
About Amrize Ltd
Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.
Fundamentals
| Revenue (TTM) | $11.81B |
| Gross Profit (TTM) | $3.03B |
| EBITDA | $2.86B |
| Operating Margin | 17.30% |
| Return on Equity | 10.20% |
| Return on Assets | 5.07% |
| Revenue/Share (TTM) | $21.36 |
| Book Value | $23.97 |
| Price-to-Book | 2.26 |
| Price-to-Sales (TTM) | 2.56 |
| EV/Revenue | 2.949 |
| EV/EBITDA | 12.40 |
| Quarterly Earnings Growth (YoY) | 3.60% |
| Quarterly Revenue Growth (YoY) | -0.40% |
| Shares Outstanding | $553.45M |
| Float | $492.83M |
| % Insiders | 7.29% |
| % Institutions | 54.23% |
Analyst Ratings
Consensus ($67.06 target)
3
Strong Buy9
Buy9
HoldData last updated: 4/7/2026